\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ is\\ a\\ well\\ appearing\\,\\ alert\\,\\ oriented\\,\\ afebrile\\,\\ pleasant\\ male\\ in\\ no\\ acute\\ distress\\.\\ \\ his\\ left\\ leg\\ is\\ modeled\\ and\\ edematous\\ with\\ two\\ well\\ healed\\ skin\\ grafts\\ at\\ the\\ proximal\\ medial\\ and\\ distal\\ medial\\ aspects\\.\\ \\ there\\ are\\ numerous\\ skin\\ to\\ erythematous\\ colored\\ nodules\\ on\\ all\\ aspects\\ of\\ the\\ left\\ lower\\ leg\\.\\ \\ the\\ nodules\\ are\\ 1\\-4\\ cm\\ in\\ diameter\\ and\\ tender\\ to\\ palpation\\.\ \(0\)\
\-\ initially\\,\\ no\\ labs\\ were\\ taken\\.\ \(0\)\
\-\ systemic\\ evaluation\\ was\\ done\\ to\\ measure\\ the\\ extent\\ of\\ the\\ disease\\ with\\ mri\\ and\\ pet\\ scans\\.\\ \\ mri\\ of\\ the\\ left\\ lower\\ extremity\\,\\ without\\ contrast\\,\\ showed\\ multiple\\ cutaneous\\ and\\ subcutaneous\\ enhancing\\ nodules\\.\\ \\ the\\ largest\\ nodule\\ was\\ at\\ the\\ anteromedial\\ aspect\\ of\\ the\\ proximal\\ leg\\ superficial\\ to\\ the\\ myocutaneous\\ flap\\ \\(with\\ infiltration\\)\\ measuring\\ 1\\.3\\ x\\ 3\\.3\\ x\\ 3\\.3\\ cm\\ \\(anterior\\-posterior\\ x\\ transverse\\ x\\ craniocaudal\\)\\.\\ \\ numerous\\ additional\\ small\\ areas\\ of\\ nodular\\ enhancement\\ were\\ identified\\ within\\ the\\ cutaneous\\ tissues\\ inferiorly\\,\\ circumferentially\\,\\ and\\ with\\ a\\ conglomeration\\ of\\ nodular\\ lesions\\ posterolaterally\\.\\ \\ pet\\ imaging\\ showed\\ multiple\\ soft\\ tissue\\ active\\ foci\\ in\\ the\\ left\\ lower\\ extremity\\ consistent\\ with\\ malignancy\\.\\ \\ \\ the\\ patient\\ underwent\\ a\\ short\\ course\\ of\\ chemotherapy\\ which\\ was\\ stopped\\ due\\ to\\ patient\\ intolerance\\.\\ \\ wide\\ excision\\ with\\ soft\\ tissue\\ coverage\\ are\\ now\\ planned\\ with\\ the\\ possibility\\ of\\ needing\\ a\\ below\\ the\\ knee\\ amputation\\.\ \(0\)\
\-\ a\\ punch\\ biopsy\\ specimen\\ from\\ nodules\\ on\\ the\\ left\\ proximal\\ medial\\ leg\\ and\\ left\\ distal\\ posterior\\ leg\\ demonstrated\\ spindled\\ cells\\ with\\ hyperchromatic\\ irregular\\ nuclei\\ and\\ variable\\ pleomorphism\\.\\ \\ they\\ were\\ isolated\\ to\\ the\\ dermis\\ and\\ subcutaneous\\ tissue\\,\\ with\\ a\\ multinodular\\ growth\\ pattern\\ and\\ a\\ prominent\\ myxoid\\ stroma\\.\\ \\ scattered\\ multinucleated\\ cells\\ were\\ also\\ present\\ as\\ were\\ perivascular\\ condensation\\ of\\ the\\ tumor\\ cells\\ without\\ vascular\\ invasion\\.\\ \\ perineural\\ invasion\\ was\\ also\\ present\\.\ \(0\)\
\-\ low\\ grade\\ myxofibrosarcoma\ \(1\)\
\-\ this\\ patient\\ is\\ \\ a\\ 76\\ year\\-old\\ man\\ with\\ a\\ past\\ medical\\ history\\ significant\\ for\\ high\\ grade\\ malignant\\ fibrous\\ histiocytoma\\ \\(mfh\\)\\.\\ \\ he\\ presented\\ with\\ multiple\\ gradually\\ enlarging\\ painful\\ nodules\\ in\\ the\\ left\\ leg\\.\\ \\ these\\ lesions\\ are\\ located\\ diffusely\\ on\\ the\\ left\\ lower\\ leg\\ and\\ have\\ been\\ slowly\\ enlarging\\ as\\ well\\ as\\ increasing\\ in\\ number\\ over\\ the\\ past\\ few\\ months\\.\\ \\ aside\\ from\\ these\\ lesions\\,\\ the\\ patient\\ has\\ no\\ complaints\\ and\\ is\\ otherwise\\ feeling\\ healthy\\.\\ \\ twice\\ in\\ the\\ past\\ three\\ years\\ the\\ patient\\ has\\ been\\ treated\\ with\\ wide\\ excisions\\ and\\ radiation\\ therapy\\ for\\ primary\\ and\\ recurrent\\ high\\ grade\\ mfh\\.\\ \\ these\\ tumors\\ also\\ presented\\ as\\ slow\\ growing\\ tender\\ erythematous\\ nodules\\ and\\ were\\ located\\ in\\ the\\ left\\ proximal\\ thigh\\,\\ left\\ proximal\\ medial\\ leg\\,\\ and\\ left\\ distal\\ medial\\ leg\\.\ \(0\)\
\-\ case\\ presented\\ by\\ shelley\\ l\\.\\ aldrich\\,\\ m\\.d\\.\\ and\\ oliver\\ j\\.\\ wisco\\,\\ d\\.o\\.\\ at\\ the\\ 2007\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ san\\ antonio\\,\\ tx\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ leg\\:\\ 0\\.3279738807313902\ \(0\)\
\-\ the\\:\\ 0\\.2600682844556366\ \(0\)\
\-\ nodules\\:\\ 0\\.23013367032466273\ \(0\)\
\-\ left\\:\\ 0\\.18113568950532127\ \(0\)\
\-\ and\\:\\ 0\\.169574465388844\ \(0\)\
\-\ medial\\:\\ 0\\.15710942873313796\ \(0\)\
\-\ proximal\\:\\ 0\\.15079031506530433\ \(0\)\
\-\ were\\:\\ 0\\.14929918328428515\ \(0\)\
\-\ mfh\\:\\ 0\\.13580336716999677\ \(0\)\
\-\ with\\:\\ 0\\.11342884723555864\ \(0\)\
\-\ cells\\:\\ 0\\.111580370003371\ \(0\)\
\-\ grade\\:\\ 0\\.10413688002361504\ \(0\)\
\-\ cutaneous\\:\\ 0\\.10026016867820141\ \(0\)\
\-\ aspects\\:\\ 0\\.09991824104144799\ \(0\)\
\-\ lower\\:\\ 0\\.09866967007136263\ \(0\)\
\-\ erythematous\\:\\ 0\\.09800017090686795\ \(0\)\
\-\ past\\:\\ 0\\.09426565723988278\ \(0\)\
\-\ patient\\:\\ 0\\.09420417338156385\ \(0\)\
\-\ wide\\:\\ 0\\.09351326402062075\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.09196350370413274\ \(0\)\
\-\ enlarging\\:\\ 0\\.09015915074339034\ \(0\)\
\-\ pet\\:\\ 0\\.08941508180948834\ \(0\)\
\-\ invasion\\:\\ 0\\.0861183201042977\ \(0\)\
\-\ of\\:\\ 0\\.08502083549771844\ \(0\)\
\-\ presented\\:\\ 0\\.08444976478843633\ \(0\)\
\-\ distal\\:\\ 0\\.08414296632902828\ \(0\)\
\-\ in\\:\\ 0\\.08406081917294052\ \(0\)\
\-\ lesions\\:\\ 0\\.08317072844671577\ \(0\)\
\-\ these\\:\\ 0\\.08177880814942548\ \(0\)\
\-\ numerous\\:\\ 0\\.08155158373554748\ \(0\)\
\-\ as\\:\\ 0\\.07757147464585029\ \(0\)\
\-\ modeled\\:\\ 0\\.0771986034895598\ \(0\)\
\-\ condensation\\:\\ 0\\.0771986034895598\ \(0\)\
\-\ excisions\\:\\ 0\\.0771986034895598\ \(0\)\
\-\ shelley\\:\\ 0\\.0771986034895598\ \(0\)\
\-\ aldrich\\:\\ 0\\.0771986034895598\ \(0\)\
\-\ wisco\\:\\ 0\\.0771986034895598\ \(0\)\
\-\ nodular\\:\\ 0\\.07688392741324829\ \(0\)\
\-\ located\\:\\ 0\\.07637101415013635\ \(0\)\
\-\ tissue\\:\\ 0\\.07596835754404276\ \(0\)\
\-\ myocutaneous\\:\\ 0\\.0737673869693569\ \(0\)\
\-\ oliver\\:\\ 0\\.0737673869693569\ \(0\)\
\-\ are\\:\\ 0\\.07326922167273553\ \(0\)\
\-\ to\\:\\ 0\\.07240852533138115\ \(0\)\
\-\ skin\\:\\ 0\\.07182078510368514\ \(0\)\
\-\ spindled\\:\\ 0\\.07133290010520128\ \(0\)\
\-\ hyperchromatic\\:\\ 0\\.07133290010520128\ \(0\)\
\-\ myxofibrosarcoma\\:\\ 0\\.07133290010520128\ \(0\)\
\-\ multiple\\:\\ 0\\.07083372783462533\ \(0\)\
\-\ tender\\:\\ 0\\.07058031490899182\ \(0\)\
\-\ well\\:\\ 0\\.07012168078014099\ \(0\)\
\-\ extremity\\:\\ 0\\.06953667214085624\ \(0\)\
\-\ pleomorphism\\:\\ 0\\.0694445653895004\ \(0\)\
\-\ also\\:\\ 0\\.06811832549505843\ \(0\)\
\-\ conglomeration\\:\\ 0\\.06790168358499839\ \(0\)\
\-\ posterolaterally\\:\\ 0\\.06790168358499839\ \(0\)\
\-\ multinucleated\\:\\ 0\\.06790168358499839\ \(0\)\
\-\ was\\:\\ 0\\.06729409662601402\ \(0\)\
\-\ needing\\:\\ 0\\.06659719560650951\ \(0\)\
\-\ antonio\\:\\ 0\\.0654671967208428\ \(0\)\
\-\ circumferentially\\:\\ 0\\.06447046706479549\ \(0\)\
\-\ perineural\\:\\ 0\\.06447046706479549\ \(0\)\
\-\ showed\\:\\ 0\\.06430610215955378\ \(0\)\
\-\ punch\\:\\ 0\\.06277230712052069\ \(0\)\
\-\ pleasant\\:\\ 0\\.062035980200639884\ \(0\)\
\-\ grafts\\:\\ 0\\.06135862509560346\ \(0\)\
\-\ colored\\:\\ 0\\.06135862509560346\ \(0\)\
\-\ coverage\\:\\ 0\\.06135862509560346\ \(0\)\
\-\ myxoid\\:\\ 0\\.060731492222151\ \(0\)\
\-\ san\\:\\ 0\\.06014764548493899\ \(0\)\
\-\ multinodular\\:\\ 0\\.05908846225255655\ \(0\)\
\-\ aside\\:\\ 0\\.05860476368043698\ \(0\)\
\-\ perivascular\\:\\ 0\\.057300275701948095\ \(0\)\
\-\ stroma\\:\\ 0\\.05690660373616218\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.0565304341989193\ \(0\)\
\-\ been\\:\\ 0\\.0562484779256487\ \(0\)\
\-\ anteromedial\\:\\ 0\\.056170276816281374\ \(0\)\
\-\ measure\\:\\ 0\\.055824823905082505\ \(0\)\
\-\ histiocytoma\\:\\ 0\\.055824823905082505\ \(0\)\
\-\ flap\\:\\ 0\\.05549292171124495\ \(0\)\
\-\ amputation\\:\\ 0\\.05549292171124495\ \(0\)\
\-\ cm\\:\\ 0\\.05544715229781051\ \(0\)\
\-\ high\\:\\ 0\\.05487011314517348\ \(0\)\
\-\ at\\:\\ 0\\.05469966315739099\ \(0\)\
\-\ dermis\\:\\ 0\\.05456883130964919\ \(0\)\
\-\ twice\\:\\ 0\\.05428194210058049\ \(0\)\
\-\ stopped\\:\\ 0\\.054004460809305585\ \(0\)\
\-\ intolerance\\:\\ 0\\.05322275886819804\ \(0\)\
\-\ nuclei\\:\\ 0\\.05322275886819804\ \(0\)\
\-\ tx\\:\\ 0\\.0529774541220916\ \(0\)\
\-\ is\\:\\ 0\\.0528792597658072\ \(0\)\
\-\ edematous\\:\\ 0\\.05184745523642488\ \(0\)\
\-\ specimen\\:\\ 0\\.051434572317589584\ \(0\)\
\-\ soft\\:\\ 0\\.05139874790875447\ \(0\)\
\-\ healed\\:\\ 0\\.05123544733783692\ \(0\)\
\-\ feeling\\:\\ 0\\.05123544733783692\ \(0\)\
\-\ without\\:\\ 0\\.05092409979814663\ \(0\)\
\-\ gradually\\:\\ 0\\.050304573431922864\ \(0\)\
\-\ posterior\\:\\ 0\\.04992448959040534\ \(0\)\
\-\ mri\\:\\ 0\\.04955787217193155\ \(0\)\
\-\ present\\:\\ 0\\.04954061072997853\ \(0\)\
\-\ planned\\:\\ 0\\.049466024478250624\ \(0\)\
\-\ largest\\:\\ 0\\.04915256563610278\ \(0\)\
\-\ seminar\\:\\ 0\\.048558467630303505\ \(0\)\
\-\ uniformed\\:\\ 0\\.048138757424947075\ \(0\)\
\-\ 2007\\:\\ 0\\.047738883611185556\ \(0\)\
\-\ infiltration\\:\\ 0\\.04760968383160076\ \(0\)\
\-\ slowly\\:\\ 0\\.04760968383160076\ \(0\)\
\-\ 76\\:\\ 0\\.04748242697962959\ \(0\)\
\-\ thigh\\:\\ 0\\.04748242697962959\ \(0\)\
\-\ growing\\:\\ 0\\.04735705548383953\ \(0\)\
\-\ services\\:\\ 0\\.04735705548383953\ \(0\)\
\-\ dermatology\\:\\ 0\\.04723351429435788\ \(0\)\
\-\ no\\:\\ 0\\.04709322706286029\ \(0\)\
\-\ variable\\:\\ 0\\.04687335691171997\ \(0\)\
\-\ superficial\\:\\ 0\\.04664149525213225\ \(0\)\
\-\ slow\\:\\ 0\\.046527904000521085\ \(0\)\
\-\ inferiorly\\:\\ 0\\.04630519585311188\ \(0\)\
\-\ isolated\\:\\ 0\\.04587662725567267\ \(0\)\
\-\ possibility\\:\\ 0\\.04489151382819465\ \(0\)\
\-\ diffusely\\:\\ 0\\.04489151382819465\ \(0\)\
\-\ alert\\:\\ 0\\.04443887004756436\ \(0\)\
\-\ number\\:\\ 0\\.04443887004756436\ \(0\)\
\-\ extent\\:\\ 0\\.04417846731139786\ \(0\)\
\-\ has\\:\\ 0\\.04409915258118853\ \(0\)\
\-\ on\\:\\ 0\\.04373757870002968\ \(0\)\
\-\ oriented\\:\\ 0\\.04352086115624395\ \(0\)\
\-\ systemic\\:\\ 0\\.04283742454093217\ \(0\)\
\-\ painful\\:\\ 0\\.042692764245944995\ \(0\)\
\-\ scans\\:\\ 0\\.04200438318340876\ \(0\)\
\-\ scattered\\:\\ 0\\.04200438318340876\ \(0\)\
\-\ afebrile\\:\\ 0\\.041680112814393835\ \(0\)\
\-\ short\\:\\ 0\\.04149135209948102\ \(0\)\
\-\ few\\:\\ 0\\.04094908982523129\ \(0\)\
\-\ healthy\\:\\ 0\\.04094908982523129\ \(0\)\
\-\ growth\\:\\ 0\\.03980451312168921\ \(0\)\
\-\ below\\:\\ 0\\.03975368761645082\ \(0\)\
\-\ complaints\\:\\ 0\\.03975368761645082\ \(0\)\
\-\ foci\\:\\ 0\\.039454982917622276\ \(0\)\
\-\ distress\\:\\ 0\\.03888745715207285\ \(0\)\
\-\ diameter\\:\\ 0\\.038796462499158926\ \(0\)\
\-\ recurrent\\:\\ 0\\.038706435892825276\ \(0\)\
\-\ appearing\\:\\ 0\\.03857316666320584\ \(0\)\
\-\ taken\\:\\ 0\\.03857316666320584\ \(0\)\
\-\ done\\:\\ 0\\.038398677570383684\ \(0\)\
\-\ from\\:\\ 0\\.03834376322006587\ \(0\)\
\-\ nodule\\:\\ 0\\.0381017200422404\ \(0\)\
\-\ tissues\\:\\ 0\\.03806013557927812\ \(0\)\
\-\ excision\\:\\ 0\\.03806013557927812\ \(0\)\
\-\ prominent\\:\\ 0\\.0380187544641354\ \(0\)\
\-\ increasing\\:\\ 0\\.0380187544641354\ \(0\)\
\-\ initially\\:\\ 0\\.03785522432840502\ \(0\)\
\-\ fibrous\\:\\ 0\\.037498441789753575\ \(0\)\
\-\ additional\\:\\ 0\\.03742115886738576\ \(0\)\
\-\ measuring\\:\\ 0\\.037344575347570845\ \(0\)\
\-\ irregular\\:\\ 0\\.03726867868471696\ \(0\)\
\-\ transverse\\:\\ 0\\.03719345666779034\ \(0\)\
\-\ malignancy\\:\\ 0\\.03613867979905025\ \(0\)\
\-\ pattern\\:\\ 0\\.03604008736908195\ \(0\)\
\-\ active\\:\\ 0\\.03584628299383272\ \(0\)\
\-\ course\\:\\ 0\\.035656817889159025\ \(0\)\
\-\ tumors\\:\\ 0\\.03550210752564087\ \(0\)\
\-\ knee\\:\\ 0\\.03460130917753946\ \(0\)\
\-\ they\\:\\ 0\\.03449176174246623\ \(0\)\
\-\ malignant\\:\\ 0\\.034410521875174384\ \(0\)\
\-\ otherwise\\:\\ 0\\.034410521875174384\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.03427683155625157\ \(0\)\
\-\ identified\\:\\ 0\\.03422394125168253\ \(0\)\
\-\ biopsy\\:\\ 0\\.03383746216451406\ \(0\)\
\-\ labs\\:\\ 0\\.03344379019872814\ \(0\)\
\-\ underwent\\:\\ 0\\.03325361542730206\ \(0\)\
\-\ now\\:\\ 0\\.03313689052589248\ \(0\)\
\-\ areas\\:\\ 0\\.032773835549942926\ \(0\)\
\-\ palpation\\:\\ 0\\.03255458957755753\ \(0\)\
\-\ three\\:\\ 0\\.03240442860776141\ \(0\)\
\-\ radiation\\:\\ 0\\.03198952094404651\ \(0\)\
\-\ vascular\\:\\ 0\\.0318689143251751\ \(0\)\
\-\ aspect\\:\\ 0\\.03114257256419196\ \(0\)\
\-\ medical\\:\\ 0\\.030679250648158792\ \(0\)\
\-\ enhancing\\:\\ 0\\.030239984477449713\ \(0\)\
\-\ treated\\:\\ 0\\.030060792733112286\ \(0\)\
\-\ primary\\:\\ 0\\.029682520992111498\ \(0\)\
\-\ demonstrated\\:\\ 0\\.029667120767326364\ \(0\)\
\-\ years\\:\\ 0\\.029590537247511442\ \(0\)\
\-\ evaluation\\:\\ 0\\.029439418567730937\ \(0\)\
\-\ his\\:\\ 0\\.029276246758644438\ \(0\)\
\-\ for\\:\\ 0\\.029262187673188635\ \(0\)\
\-\ all\\:\\ 0\\.028735605793180952\ \(0\)\
\-\ two\\:\\ 0\\.028666972641758156\ \(0\)\
\-\ he\\:\\ 0\\.028585340936246692\ \(0\)\
\-\ months\\:\\ 0\\.028098634038043555\ \(0\)\
\-\ significant\\:\\ 0\\.027871610615063117\ \(0\)\
\-\ enhancement\\:\\ 0\\.027784942778840617\ \(0\)\
\-\ due\\:\\ 0\\.027748069425581473\ \(0\)\
\-\ therapy\\:\\ 0\\.027735813925707464\ \(0\)\
\-\ low\\:\\ 0\\.02769915355999449\ \(0\)\
\-\ over\\:\\ 0\\.026841759894488833\ \(0\)\
\-\ consistent\\:\\ 0\\.02617458208614984\ \(0\)\
\-\ acute\\:\\ 0\\.026113701095621347\ \(0\)\
\-\ man\\:\\ 0\\.025556182362269083\ \(0\)\
\-\ imaging\\:\\ 0\\.02536895301753348\ \(0\)\
\-\ tumor\\:\\ 0\\.025249438292981933\ \(0\)\
\-\ small\\:\\ 0\\.02490069964259057\ \(0\)\
\-\ case\\:\\ 0\\.0242516943837802\ \(0\)\
\-\ have\\:\\ 0\\.024114876225115704\ \(0\)\
\-\ contrast\\:\\ 0\\.023454733663653374\ \(0\)\
\-\ within\\:\\ 0\\.022232930653685052\ \(0\)\
\-\ which\\:\\ 0\\.0219500903990632\ \(0\)\
\-\ male\\:\\ 0\\.021492876146776883\ \(0\)\
\-\ by\\:\\ 0\\.020499400642349744\ \(0\)\
\-\ disease\\:\\ 0\\.020263176946155904\ \(0\)\
\-\ there\\:\\ 0\\.019207569258849973\ \(0\)\
\-\ history\\:\\ 0\\.018442977216006427\ \(0\)\
\-\ this\\:\\ 0\\.01658737918014059\ \(0\)\
